Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC.CELZ · Entity 8127 | Director · President & CEO | June 27, 2023 | June 29, 2023 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC.
Report date June 27, 2023 · Filed June 29, 2023
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 12,209 |
Ending reported balance
After 2023-06-28 transaction · row 4
4 source rows · reconciled sequenceRow 1 · 2023-06-27 · Purchase · Acquired 300 · Balance 11,509 Row 2 · 2023-06-27 · Purchase · Acquired 300 · Balance 11,809 Row 3 · 2023-06-27 · Purchase · Acquired 200 · Balance 12,009 Row 4 · 2023-06-28 · Purchase · Acquired 200 · Balance 12,209 |
| Common StockSEC Table I · non-derivative | IndirectEntity | 22,695 |
Reported balance
Holding disclosure · report date 2023-06-27 · row 5
Holding and transaction disclosures are not merged.
1 source rowRow 5 · Balance 22,695 F1: Owned by Creative Medical Health, Inc., of which Mr. Warbington serves as President and Chief Executive Officer. |
Filing footnotes · ownership attribution and instrument terms
F1: Owned by Creative Medical Health, Inc., of which Mr. Warbington serves as President and Chief Executive Officer.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 28, 2023 Filed Jun 29, 2023 17:37 UTC | CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. CELZ · Entity 8127 | PurchaseCommon Stock | 200 | $4.36 | $872.00 |
DisclosureSEC source: 0001477932-23-004914 · form4.xml · nonDerivative · entry 4 Warbington Timothy · CIK 0001674492 · Director · President & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,209 Read SEC document |
| June 27, 2023 Filed Jun 29, 2023 17:37 UTC | CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. CELZ · Entity 8127 | PurchaseCommon Stock | 200 | $4.48 | $896.00 |
DisclosureSEC source: 0001477932-23-004914 · form4.xml · nonDerivative · entry 3 Warbington Timothy · CIK 0001674492 · Director · President & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,009 Read SEC document |
| June 27, 2023 Filed Jun 29, 2023 17:37 UTC | CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. CELZ · Entity 8127 | PurchaseCommon Stock | 300 | $4.45 | $1,335.00 |
DisclosureSEC source: 0001477932-23-004914 · form4.xml · nonDerivative · entry 2 Warbington Timothy · CIK 0001674492 · Director · President & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,809 Read SEC document |
| June 27, 2023 Filed Jun 29, 2023 17:37 UTC | CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. CELZ · Entity 8127 | PurchaseCommon Stock | 300 | $4.40 | $1,320.00 |
DisclosureSEC source: 0001477932-23-004914 · form4.xml · nonDerivative · entry 1 Warbington Timothy · CIK 0001674492 · Director · President & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,509 Read SEC document |
| November 22, 2022 Filed Nov 23, 2022 09:09 UTC | CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. CELZ · Entity 8127 | PurchaseCommon Stock | 200 | $0.38 | $75.42 |
DisclosureSEC source: 0001477932-22-008858 · form4.xml · nonDerivative · entry 4 Warbington Timothy · CIK 0001674492 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 112,087 Read SEC document |
| November 22, 2022 Filed Nov 23, 2022 09:09 UTC | CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. CELZ · Entity 8127 | PurchaseCommon Stock | 9,800 | $0.39 | $3,822.00 |
DisclosureSEC source: 0001477932-22-008858 · form4.xml · nonDerivative · entry 3 Warbington Timothy · CIK 0001674492 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 111,887 Read SEC document |
| November 21, 2022 Filed Nov 23, 2022 09:09 UTC | CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. CELZ · Entity 8127 | PurchaseCommon Stock | 5,000 | $0.39 | $1,965.00 |
DisclosureSEC source: 0001477932-22-008858 · form4.xml · nonDerivative · entry 2 Warbington Timothy · CIK 0001674492 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 102,087 Read SEC document |
| November 21, 2022 Filed Nov 23, 2022 09:09 UTC | CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. CELZ · Entity 8127 | PurchaseCommon Stock | 10,000 | $0.40 | $4,000.00 |
DisclosureSEC source: 0001477932-22-008858 · form4.xml · nonDerivative · entry 1 Warbington Timothy · CIK 0001674492 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 97,087 Read SEC document |
| September 27, 2022 Filed Sep 28, 2022 17:01 UTC | CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. CELZ · Entity 8127 | PurchaseCommon Stock | 20,000 | $0.50 | $10,000.00 |
DisclosureSEC source: 0001477932-22-007299 · form4.xml · nonDerivative · entry 1 Warbington Timothy · CIK 0001674492 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 87,087 Read SEC document |
| September 22, 2022 Filed Sep 22, 2022 12:24 UTC | CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. CELZ · Entity 8127 | PurchaseCommon Stock | 12,000 | $0.54 | $6,480.00 |
DisclosureSEC source: 0001477932-22-007108 · form4.xml · nonDerivative · entry 5 Warbington Timothy · CIK 0001674492 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 67,087 Read SEC document |
| September 21, 2022 Filed Sep 22, 2022 12:24 UTC | CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. CELZ · Entity 8127 | PurchaseCommon Stock | 20,000 | $0.61 | $12,100.00 |
DisclosureSEC source: 0001477932-22-007108 · form4.xml · nonDerivative · entry 4 Warbington Timothy · CIK 0001674492 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 55,087 Read SEC document |
| September 21, 2022 Filed Sep 22, 2022 12:24 UTC | CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. CELZ · Entity 8127 | PurchaseCommon Stock | 500 | $0.63 | $314.00 |
DisclosureSEC source: 0001477932-22-007108 · form4.xml · nonDerivative · entry 3 Warbington Timothy · CIK 0001674492 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,087 Read SEC document |
| September 21, 2022 Filed Sep 22, 2022 12:24 UTC | CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. CELZ · Entity 8127 | PurchaseCommon Stock | 4,500 | $0.64 | $2,873.25 |
DisclosureSEC source: 0001477932-22-007108 · form4.xml · nonDerivative · entry 2 Warbington Timothy · CIK 0001674492 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,587 Read SEC document |
| September 21, 2022 Filed Sep 22, 2022 12:24 UTC | CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. CELZ · Entity 8127 | PurchaseCommon Stock | 5,000 | $0.61 | $3,050.00 |
DisclosureSEC source: 0001477932-22-007108 · form4.xml · nonDerivative · entry 1 Warbington Timothy · CIK 0001674492 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,087 Read SEC document |
| June 06, 2022 Filed Jun 7, 2022 16:02 UTC | CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. CELZ · Entity 8127 | PurchaseCommon Stock | 15,000 | $0.91 | $13,689.00 |
DisclosureSEC source: 0001477932-22-004177 · form4.xml · nonDerivative · entry 3 Warbington Timothy · CIK 0001674492 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,087 Read SEC document |
| June 06, 2022 Filed Jun 7, 2022 16:02 UTC | CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. CELZ · Entity 8127 | PurchaseCommon Stock | 8,000 | $0.92 | $7,357.60 |
DisclosureSEC source: 0001477932-22-004177 · form4.xml · nonDerivative · entry 2 Warbington Timothy · CIK 0001674492 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,087 Read SEC document |
| June 06, 2022 Filed Jun 7, 2022 16:02 UTC | CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. CELZ · Entity 8127 | PurchaseCommon Stock | 2,000 | $0.92 | $1,837.40 |
DisclosureSEC source: 0001477932-22-004177 · form4.xml · nonDerivative · entry 1 Warbington Timothy · CIK 0001674492 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,087 Read SEC document |
| February 09, 2022 Filed Feb 11, 2022 17:01 UTC | CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. CELZ · Entity 8127 | GrantStock Option (Right to Buy) · Derivative | 58,580 | $0.00 Strike: $1.69 | $0.00 |
DisclosureSEC source: 0001477932-22-000693 · form4.xml · derivative · entry 1 Warbington Timothy · CIK 0001674492 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 58,580 Underlying: Common Stock · 58,580 shares Expires 2032-02-09 F1 · derivative.exercise_date: The options vests immediately as to 25% of the shares subject to the option, and in three equal installments of 25% of the shares subject to the option on each of the next three annual anniversary dates of the grant date. Read SEC document |
| January 08, 2021 Filed Jan 8, 2021 16:45 UTC | CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. CELZ · Entity 8127 | OtherCommon Stock | 44,642,857 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001477932-21-000138 · form4.xml · nonDerivative · entry 1 Warbington Timothy · CIK 0001674492 · Director · President & CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · Entity Disclosed balance after: 113,474,233 F1 · kind: The shares of common stock were issued by the issuer to Creative Medical Health, Inc. ("CMH") in satisfaction of a $50,000 obligation owed to CMH under the Patent Purchase Agreement, dated May 17, 2017, as amended on November 14, 2017, between the issuer, its wholly-owned subsidiary StemSpine, LLC, and the Reporting Person (the "Patent Agreement"). Pursuant to the Patent Agreement, the number of shares issued was calculated based on a 30% discount to the closing trading price of the common stock of $.0016 on December 9, 2020. Mr. Warbington is President of CMH and disclaims beneficial ownership of the shares of common stock owned by CMH except to the extent of his pecuniary interest therein. F1 · price: The shares of common stock were issued by the issuer to Creative Medical Health, Inc. ("CMH") in satisfaction of a $50,000 obligation owed to CMH under the Patent Purchase Agreement, dated May 17, 2017, as amended on November 14, 2017, between the issuer, its wholly-owned subsidiary StemSpine, LLC, and the Reporting Person (the "Patent Agreement"). Pursuant to the Patent Agreement, the number of shares issued was calculated based on a 30% discount to the closing trading price of the common stock of $.0016 on December 9, 2020. Mr. Warbington is President of CMH and disclaims beneficial ownership of the shares of common stock owned by CMH except to the extent of his pecuniary interest therein. Read SEC document |
| September 30, 2020 Filed Oct 2, 2020 16:40 UTC | CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. CELZ · Entity 8127 | OtherCommon Stock | 42,328,042 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001477932-20-005720 · form4.xml · nonDerivative · entry 1 Warbington Timothy · CIK 0001674492 · Director · President & CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · Entity Disclosed balance after: 68,831,376 F1 · kind: The shares of common stock were issued by the issuer to Creative Medical Health, Inc. ("CMH") in satisfaction of a $40,000 obligation owed to CMH under the Patent Purchase Agreement, dated May 17, 2017, as amended on November 14, 2017, between the issuer, its wholly-owned subsidiary StemSpine, LLC, and the Reporting Person (the "Patent Agreement"). Pursuant to the Patent Agreement, the number of shares issued was calculated based on a 30% discount to the closing trading price of the common stock of $.0027 on September 28, 2020, and then doubled because such trading price was below $0.01. Mr. Warbington is President of CMH and disclaims beneficial ownership of the shares of common stock owned by CMH except to the extent of his pecuniary interest therein. F1 · price: The shares of common stock were issued by the issuer to Creative Medical Health, Inc. ("CMH") in satisfaction of a $40,000 obligation owed to CMH under the Patent Purchase Agreement, dated May 17, 2017, as amended on November 14, 2017, between the issuer, its wholly-owned subsidiary StemSpine, LLC, and the Reporting Person (the "Patent Agreement"). Pursuant to the Patent Agreement, the number of shares issued was calculated based on a 30% discount to the closing trading price of the common stock of $.0027 on September 28, 2020, and then doubled because such trading price was below $0.01. Mr. Warbington is President of CMH and disclaims beneficial ownership of the shares of common stock owned by CMH except to the extent of his pecuniary interest therein. F1 · ownership.nature: The shares of common stock were issued by the issuer to Creative Medical Health, Inc. ("CMH") in satisfaction of a $40,000 obligation owed to CMH under the Patent Purchase Agreement, dated May 17, 2017, as amended on November 14, 2017, between the issuer, its wholly-owned subsidiary StemSpine, LLC, and the Reporting Person (the "Patent Agreement"). Pursuant to the Patent Agreement, the number of shares issued was calculated based on a 30% discount to the closing trading price of the common stock of $.0027 on September 28, 2020, and then doubled because such trading price was below $0.01. Mr. Warbington is President of CMH and disclaims beneficial ownership of the shares of common stock owned by CMH except to the extent of his pecuniary interest therein. Read SEC document |
| June 03, 2020 Filed Jun 5, 2020 16:05 UTC | CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. CELZ · Entity 8127 | OtherCommon Stock | 19,736,842 | $0.00 | $75,000.00 |
DisclosureSEC source: 0001104659-20-070295 · tm2021915-2_4.xml · nonDerivative · entry 1 Warbington Timothy · CIK 0001674492 · Director · President & CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · Entity Disclosed balance after: 26,503,334 F1 · kind: The shares of common stock were issued by the issuer to Creative Medical Health, Inc. ("CMH") in exchange for the cancellation of $75,000 of accrued obligations owed to CMH for management services provided to the Issuer. Mr. Warbington is President of CMH and disclaims beneficial ownership of the shares of common stock owned by CMH except to the extent of his pecuniary interest therein. F1 · ownership.nature: The shares of common stock were issued by the issuer to Creative Medical Health, Inc. ("CMH") in exchange for the cancellation of $75,000 of accrued obligations owed to CMH for management services provided to the Issuer. Mr. Warbington is President of CMH and disclaims beneficial ownership of the shares of common stock owned by CMH except to the extent of his pecuniary interest therein. Read SEC document |
| February 17, 2020 Filed Feb 19, 2020 18:04 UTC | CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. CELZ · Entity 8127 | OtherCommon Stock | 2,250,000 | $0.02 | $45,000.00 |
DisclosureSEC source: 0001104659-20-022930 · tm209399-2_4.xml · nonDerivative · entry 1 Warbington Timothy · CIK 0001674492 · Director · President & CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · Entity Disclosed balance after: 6,766,492 F1 · kind: The shares of common stock were issued by the issuer to Creative Medical Health, Inc. ("CMH") in exchange for the cancellation of $45,000 of accrued obligations owed to CMH for management services provided to the Issuer. Mr. Warbington is President of CMH and disclaims beneficial ownership of the shares of common stock owned by CMH except to the extent of his pecuniary interest therein. F1 · ownership.nature: The shares of common stock were issued by the issuer to Creative Medical Health, Inc. ("CMH") in exchange for the cancellation of $45,000 of accrued obligations owed to CMH for management services provided to the Issuer. Mr. Warbington is President of CMH and disclaims beneficial ownership of the shares of common stock owned by CMH except to the extent of his pecuniary interest therein. Read SEC document |
| December 13, 2019 Filed Dec 13, 2019 16:04 UTC | CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. CELZ · Entity 8127 | OtherCommon Stock | 500,000,000 | $0.00 | $50,000.00 |
DisclosureSEC source: 0001104659-19-072558 · tm1925194d1_form4.xml · nonDerivative · entry 1 Warbington Timothy · CIK 0001674492 · Director · President & CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · Entity Disclosed balance after: 677,473,616 F1 · kind: The shares of common stock were issued to Creative Medical Health, Inc. ("CMH") as a $50,000 partial payment of the $100,000 payment owed to CMH under Section 3.2 of the Patent Purchase Agreement, dated May 17, 2017, as amended on November 14, 2017, between the issuer, its wholly-owned subsidiary StemSpine, LLC, and CMH. Mr. Warbington is the President of CMH and disclaims beneficial ownership of the shares of common stock owned by CMH except to the extent of his pecuniary interest therein. F1 · ownership.nature: The shares of common stock were issued to Creative Medical Health, Inc. ("CMH") as a $50,000 partial payment of the $100,000 payment owed to CMH under Section 3.2 of the Patent Purchase Agreement, dated May 17, 2017, as amended on November 14, 2017, between the issuer, its wholly-owned subsidiary StemSpine, LLC, and CMH. Mr. Warbington is the President of CMH and disclaims beneficial ownership of the shares of common stock owned by CMH except to the extent of his pecuniary interest therein. Read SEC document |
| November 05, 2019 Filed Dec 13, 2019 16:02 UTC | CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. CELZ · Entity 8127 | OtherCommon Stock | 100,000,000 | $0.00 | $50,000.00 |
DisclosureSEC source: 0001104659-19-072554 · tv531793_form4.xml · nonDerivative · entry 1 Warbington Timothy · CIK 0001674492 · Director · President & CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · Entity Disclosed balance after: 177,473,616 F1 · kind: The shares of common stock were issued by the issuer to Creative Medical Health, Inc. ("CMH") in exchange for the cancellation of $50,000 of accrued obligations owed to CMH for management services provided to the Issuer. Mr. Warbington is President of CMH and disclaims beneficial ownership of the shares of common stock owned by CMH except to the extent of his pecuniary interest therein. F1 · ownership.nature: The shares of common stock were issued by the issuer to Creative Medical Health, Inc. ("CMH") in exchange for the cancellation of $50,000 of accrued obligations owed to CMH for management services provided to the Issuer. Mr. Warbington is President of CMH and disclaims beneficial ownership of the shares of common stock owned by CMH except to the extent of his pecuniary interest therein. Read SEC document |
| June 30, 2019 Filed Jul 3, 2019 11:31 UTC | CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. CELZ · Entity 8127 | OtherCommon Stock | 10,000,000 | $0.01 | $60,000.00 |
DisclosureSEC source: 0001144204-19-033713 · tv524786_4.xml · nonDerivative · entry 1 Warbington Timothy · CIK 0001674492 · Director · President & CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · Entity Disclosed balance after: 77,473,616 F1 · kind: The shares of common stock were issued by the issuer to Creative Medical Health, Inc. ("CMH") in exchange for the cancellation of $60,000 of accrued obligations owed to CMH for management services provided to the Issuer. Mr. Warbington is President of CMH and disclaims beneficial ownership of the shares of common stock owned by CMH except to the extent of his pecuniary interest therein. F1 · ownership.nature: The shares of common stock were issued by the issuer to Creative Medical Health, Inc. ("CMH") in exchange for the cancellation of $60,000 of accrued obligations owed to CMH for management services provided to the Issuer. Mr. Warbington is President of CMH and disclaims beneficial ownership of the shares of common stock owned by CMH except to the extent of his pecuniary interest therein. Read SEC document |
| October 17, 2018 Filed Oct 18, 2018 18:23 UTC | CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. CELZ · Entity 8127 | ConversionCommon Stock | 4,444,444 | $0.02 | $99,999.99 |
DisclosureSEC source: 0001144204-18-054451 · tv505076_4.xml · nonDerivative · entry 2 Warbington Timothy · CIK 0001674492 · Director · President & CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · Entity Disclosed balance after: 72,955,661 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · ownership.nature: Shares are held by Creative Medical Health, of which Mr. Warbington is President. Mr Warbington disclaims beneficial ownership of such shares of common stock except to the extent of his pecuniary interest therein. Read SEC document |
| April 11, 2018 Filed Apr 13, 2018 17:57 UTC | CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. CELZ · Entity 8127 | ConversionCommon Stock | 9,855,290 | $0.01 | $136,003.00 |
DisclosureSEC source: 0001553997-18-000017 · primary_doc.xml · nonDerivative · entry 2 Warbington Timothy · CIK 0001674492 · Director · President & CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · Entity Disclosed balance after: 68,511,217 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · ownership.nature: Shares are held by Creative Medical Health, of which Mr. Warbington is President. Mr. Warbington disclaims beneficial ownership of such shares of common stock except to the extent of his pecuniary interest therein. Read SEC document |
| August 29, 2017 Filed Aug 31, 2017 12:41 UTC | CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. CELZ · Entity 8127 | SaleCommon Stock | 5,000 | $0.20 | $1,000.00 |
DisclosureSEC source: 0001441557-17-000032 · primary_doc.xml · nonDerivative · entry 2 Warbington Timothy · CIK 0001674492 · Director · CEO & President · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · Entity Disclosed balance after: 58,655,927 F1 · ownership.nature: Shares are held by Creative Medical Health, of which Mr. Warbington is President. Mr. Warbington disclaims beneficial ownership of such shares of common stock except to the extent of his pecuniary interest therein. Read SEC document |
| June 05, 2017 Filed Jun 7, 2017 17:26 UTC | CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. CELZ · Entity 8127 | SaleCommon Stock | 2,800 | $0.30 | $840.00 |
DisclosureSEC source: 0001441557-17-000020 · primary_doc.xml · nonDerivative · entry 3 Warbington Timothy · CIK 0001674492 · Director · President & CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · Entity Disclosed balance after: 58,605,927 F1 · balance_after: Shares are held by Creative Medical Health, of which Mr. Warbington is President. Mr. Warbington disclaims beneficial ownership of such shares of common stock except to the extent of his pecuniary interest therein. Read SEC document |
| June 05, 2017 Filed Jun 7, 2017 17:26 UTC | CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. CELZ · Entity 8127 | SaleCommon Stock | 2,500 | $0.31 | $775.00 |
DisclosureSEC source: 0001441557-17-000020 · primary_doc.xml · nonDerivative · entry 2 Warbington Timothy · CIK 0001674492 · Director · President & CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · Entity Disclosed balance after: 58,608,727 F1 · balance_after: Shares are held by Creative Medical Health, of which Mr. Warbington is President. Mr. Warbington disclaims beneficial ownership of such shares of common stock except to the extent of his pecuniary interest therein. Read SEC document |
| June 02, 2017 Filed Jun 5, 2017 18:13 UTC | CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. CELZ · Entity 8127 | SaleCommon Stock | 2,200 | $0.42 | $924.00 |
DisclosureSEC source: 0001441557-17-000018 · primary_doc.xml · nonDerivative · entry 3 Warbington Timothy · CIK 0001674492 · Director · President & CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · Entity Disclosed balance after: 58,611,227 F1 · ownership.nature: Shares are held by Creative Medical Health, of which Mr. Warbington is President. Mr. Warbington disclaims beneficial ownership of such shares of common stock except to the extent of his pecuniary interest therein. Read SEC document |
| June 02, 2017 Filed Jun 5, 2017 18:13 UTC | CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. CELZ · Entity 8127 | SaleCommon Stock | 3,500 | $0.40 | $1,400.00 |
DisclosureSEC source: 0001441557-17-000018 · primary_doc.xml · nonDerivative · entry 2 Warbington Timothy · CIK 0001674492 · Director · President & CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · Entity Disclosed balance after: 58,613,427 F1 · ownership.nature: Shares are held by Creative Medical Health, of which Mr. Warbington is President. Mr. Warbington disclaims beneficial ownership of such shares of common stock except to the extent of his pecuniary interest therein. Read SEC document |
| May 18, 2017 Filed May 19, 2017 17:39 UTC | CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. CELZ · Entity 8127 | SaleCommon Stock | 1,400 | $0.45 | $630.00 |
DisclosureSEC source: 0001441557-17-000014 · primary_doc.xml · nonDerivative · entry 2 Warbington Timothy · CIK 0001674492 · Director · President & CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · Entity Disclosed balance after: 58,616,927 F1 · ownership.nature: Shares are held by Creative Medical Health, of which Mr. Warbington is President. Mr. Warbington disclaims beneficial ownership of such shares of common stock except to the extent of his pecuniary interest therein. Read SEC document |
| December 31, 2016 Filed Jan 4, 2017 12:06 UTC | CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. CELZ · Entity 8127 | SaleCommon Stock | 2,935,609 | $0.10 | $293,560.90 |
DisclosureSEC source: 0001441557-17-000002 · primary_doc.xml · nonDerivative · entry 3 Warbington Timothy · CIK 0001674492 · Director · President & CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · Entity Disclosed balance after: 62,061,059 F3 · kind: The transaction reported hereby represents a cancellation of debt owed by the reporting party to the purchaser. The total amount of debt exchanged for the common shares was $293,560.91, or $0.10 per share, the same price as shares of common stock purchased by the reporting party on September 30, 2016. As an incentive to enter into the transaction the reporting party granted to the purchaser an option to purchase up to 293,561 shares of the Issuer at $0.10 per share with such option expiring August 1, 2019. F1 · ownership.nature: Shares are held by Creative Medical Health, of which Mr. Warbington is President. Mr. Warbington disclaims beneficial ownership of such shares of common stock except to the extent of his pecuniary interest therein. Read SEC document |
| December 31, 2016 Filed Jan 6, 2017 17:53 UTC Amendment | CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. CELZ · Entity 8127 | SaleCommon Stock | 2,935,609 | $0.10 | $293,560.90 |
DisclosureSEC source: 0001441557-17-000004 · primary_doc.xml · nonDerivative · entry 4 Warbington Timothy · CIK 0001674492 · Director · President & CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · Entity Disclosed balance after: 58,618,267 F3 · kind: The transaction reported hereby represents a cancellation of debt owed by the reporting party to the purchaser. The total amount of debt exchanged for the common shares was $293,560.91, or $0.10 per share, the same price as shares of common stock purchased by the reporting party on September 30, 2016. As an incentive to enter into the transaction the reporting party granted to the purchaser an option to purchase up to 293,561 shares of the Issuer at $0.10 per share with such option expiring August 1, 2019. F1 · ownership.nature: Shares are held by Creative Medical Health, of which Mr. Warbington is President. Mr. Warbington disclaims beneficial ownership of such shares of common stock except to the extent of his pecuniary interest therein. Read SEC document |
| December 18, 2016 Filed Jan 6, 2017 17:53 UTC Amendment | CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. CELZ · Entity 8127 | SaleCommon Stock | 3,412,791 | $0.01 | $34,127.91 |
DisclosureSEC source: 0001441557-17-000004 · primary_doc.xml · nonDerivative · entry 3 Warbington Timothy · CIK 0001674492 · Director · President & CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · Entity Disclosed balance after: 61,553,876 F1 · ownership.nature: Shares are held by Creative Medical Health, of which Mr. Warbington is President. Mr. Warbington disclaims beneficial ownership of such shares of common stock except to the extent of his pecuniary interest therein. Read SEC document |
| September 30, 2016 Filed Nov 14, 2016 16:11 UTC | CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. CELZ · Entity 8127 | PurchaseWarrants · Derivative | 30,000 | $0.00 Strike: $0.10 | $0.00 |
DisclosureSEC source: 0001441557-16-000105 · primary_doc.xml · derivative · entry 3 Warbington Timothy · CIK 0001674492 · Director · President & CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · Entity Disclosed balance after: 30,000 Underlying: Common Stock · 30,000 shares Expires 2026-09-30 F2 · ownership.nature: Warrants are held by Creative Medical Health, of which Mr. Warbington is President. Mr. Warbington disclaims beneficial ownership of such shares of common stock except to the extent of his pecuniary interest therein. Read SEC document |
| September 30, 2016 Filed Nov 14, 2016 16:11 UTC | CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. CELZ · Entity 8127 | PurchaseCommon Stock | 300,000 | $0.10 | $30,000.00 |
DisclosureSEC source: 0001441557-16-000105 · primary_doc.xml · nonDerivative · entry 2 Warbington Timothy · CIK 0001674492 · Director · President & CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · Entity Disclosed balance after: 64,996,667 F1 · ownership.nature: Shares are held by Creative Medical Health, of which Mr. Warbington is President. Mr. Warbington disclaims beneficial ownership of such shares of common stock except to the extent of his pecuniary interest therein. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.